Macrogenics (MGNX) Short-term Investments (2015 - 2019)
Macrogenics' (MGNX) quarterly Short-term Investments came in at $89.3 million in Q4 2019, up 601.09% year-on-year from $12.7 million in Q4 2018, and up 601.09% on a QoQ basis from $12.7 million in Q4 2018.
Macrogenics (MGNX) Short-term Investments (2015 - 2019) Analysis & Trends
Macrogenics (MGNX) has 5 years of Short-term Investments data on file, last reported at $89.3 million in Q4 2019.
- On a quarterly basis, Short-term Investments rose 601.09% year-over-year to $89.3 million in Q4 2019; TTM through Dec 2019 was $89.3 million, a 601.09% increase from a year earlier, with the FY2019 full-year figure at $89.3 million, up 601.09% from the prior year.
- Short-term Investments for Q4 2019 stood at $89.3 million, up from $12.7 million in the prior quarter.
- Over the last five years, Short-term Investments for MGNX reached as high as $192.9 million in Q4 2016 and fell as low as $12.7 million in Q4 2018.
- Historically, Short-term Investments has averaged $106.2 million across 5 years, with a median of $93.4 million in 2017.
- Across the five-year window, Short-term Investments slumped 86.36% in 2018 and jumped 601.09% in 2019, its largest moves.
- Year by year, Short-term Investments stood at $142.9 million in 2015, then soared by 35.01% to $192.9 million in 2016, then plunged by 51.58% to $93.4 million in 2017, then slumped by 86.36% to $12.7 million in 2018, then soared by 601.09% to $89.3 million in 2019.
- Per Business Quant data, the three most recent Short-term Investments figures were $89.3 million in Q4 2019, $12.7 million in Q4 2018, and $93.4 million in Q4 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Macrogenics | 254.43 Mn | 187.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 89.28 Mn |
| Dec 31, 2018 | 12.74 Mn |
| Dec 31, 2017 | 93.39 Mn |
| Dec 31, 2016 | 192.90 Mn |
| Dec 31, 2015 | 142.88 Mn |